Carilion Clinic
Carilion Clinic
Roanoke, Virginia, United States26 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation. | cardiovascular disorder, heart disorder, heart failure, heart valve disorder, tricuspid valve disorder, tricuspid valve insufficiency | Not yet recruiting | Not applicable | 2026-10-09 | NCT06458907 | |
| A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, vascular disorder | Recruiting | Phase 3 | 2026-10-08 | NCT07613294 | |
| A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia | Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, hypertriglyceridemia, metabolic disease | Recruiting | Phase 2 | 2026-10-08 | NCT07269210 | |
| LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis: | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Recruiting | Phase 2 | 2026-10-08 | NCT07186101 | |
| A Study of Brenipatide in Participants With Opioid Use Disorder | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Phase 2 | 2026-10-07 | NCT07420283 | |
| Alleviant ALLAY-HFrEF Study | cardiovascular disorder, heart disorder, heart failure | Recruiting | Not applicable | 2026-10-06 | NCT06812533 | |
| A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart | cardiovascular disorder, heart disorder, heart failure | Recruiting | Phase 3 | 2026-10-01 | NCT06935370 | |
| Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, vascular disorder | Recruiting | Phase 3 | 2026-09-24 | NCT07157774 | |
| A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis. | Bacterial Infections and Mycoses, Fungemia, Infections, Inflammation, Invasive Fungal Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, Torulopsis, candidemia, candidiasis, candidiasis, invasive, fungal infectious disease | Recruiting | Phase 3 | 2026-09-14 | NCT05421858 | |
| TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I) | cardiovascular disorder, heart disorder, heart failure, heart valve disorder, tricuspid valve disorder, tricuspid valve insufficiency | Active, not recruiting | Not applicable | 2026-08-28 | NCT06137807 | |
| Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study | Arm Injuries, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Rotator Cuff Injuries, Rotator Cuff Tears, Rupture, Shoulder Injuries, Tendon Injuries, bone fracture, disease, humerus fracture, injury | Active, not recruiting | Not stated | 2026-08-28 | NCT05868148 | |
| Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function | Arterial Occlusive Diseases, Infarction, Necrosis, Non-ST Elevated Myocardial Infarction, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Ventricular Dysfunction, Ventricular Dysfunction, Left, anterolateral myocardial infarction, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, inferior myocardial infarction, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Active, not recruiting | Not applicable | 2026-07-28 | NCT04763200 | |
| On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study | Thrombotic and Bleeding Events | Active, not recruiting | Not stated | 2026-07-14 | NCT02677974 | |
| A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression | Depressive Disorder, Treatment-Resistant, depressive disorder, mood disorder, psychiatric disorder | Recruiting | Not applicable | 2026-06-15 | NCT03887715 | |
| Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy | Embolism, Embolism and Thrombosis, cardiovascular disorder, lung disorder, pulmonary embolism, respiratory system disorder, vascular disorder | Recruiting | Phase 3 | 2026-05-18 | NCT05591118 | |
| A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Active, not recruiting | Phase 3 | 2026-04-20 | NCT03519945 | |
| Pectoral Block in Breast Reduction for Pain Control | Macromastia (Symptomatic) | Recruiting | Phase 4 | 2026-04-14 | NCT07527039 | |
| ADAPT - A Patient Registry of the Real-world Use of Orenitram® | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Active, not recruiting | Not stated | 2026-04-02 | NCT03045029 | |
| A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Active, not recruiting | Phase 4 | 2025-12-09 | NCT05203510 | |
| NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness | Acute Aortic Syndrome, Aneurysm, Aortic Dissection, Arterial Occlusive Diseases, Dissection, Blood Vessel, Penetrating Atherosclerotic Ulcer, aortic aneurysm, aortic disorder, arteriosclerosis disorder, cardiovascular disorder, vascular disorder | Recruiting | Not applicable | 2025-10-20 | NCT04471909 | |
| IMPact on Revascularization Outcomes of IVUS Guided Treatment of Complex Lesions and Economic Impact | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, vascular disorder | Active, not recruiting | Not applicable | 2025-09-12 | NCT04221815 | |
| Adherus™ Dural Sealant in Spinal Procedures | Cerebrospinal Fluid Otorrhea, Craniocerebral Trauma, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cerebrospinal fluid leak, injury, nervous system disorder, nervous system injury | Enrolling by invitation | Not applicable | 2025-02-24 | NCT04498026 | |
| Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting | Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Enrolling by invitation | Not applicable | 2025-01-20 | NCT04451044 | |
| Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT) | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium difficile colitis, Clostridium infectious disease, Digestive System Diseases, Infections, bacterial infectious disease, digestive system disorder, enterocolitis, gastroenteritis, gram-positive bacterial infections, intestinal disorder | Recruiting | Phase 2 | 2024-10-26 | NCT04305769 | |
| Surviving PEA in Roanoke (SPEAR) Study | cardiac arrest, cardiovascular disorder, heart disorder | Recruiting | Phase 2 / Phase 3 | 2022-03-17 | NCT05283850 |